FDA Approved: TRYVIO — Supplemental Application (Idorsia Pharmaceuticals Ltd)

View source ↗

Summary

The FDA approved a supplemental application for TRYVIO (aprocitentan) from Idorsia Pharmaceuticals Ltd, expanding its regulatory approval.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Arterial Hypertension

Drugs mentioned

• TRYVIO (APROCITENTAN)

Snippet

SUPPL AP for TRYVIO (APROCITENTAN)